Dasatinib could increase risk for pulmonary hypertension
The FDA has warned that dasatinib may increase the risk for pulmonary arterial hypertension.
A Heart and Stroke Foundation researcher has discovered that gene therapy could be useful in treating pulmonary hypertension.